BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Role of <i>Lactobacillus reuteri</i> in Human Health and Diseases. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 9 Issue Pages: 757 Pub: 2018 Epub: 2018 Apr 19 Authors Mu Q , Tavella VJ , Luo XM , |
|
|
Lactobacillus reuteri improves the development and maturation of fecal microbiota in piglets through mother-to-infant microbe and metabolite vertical transmission. ✅
Go to Publication ✅
Microbiome (Microbiome ) Vol: 10 Issue 1 Pages: 211 Pub: 2022 Dec 2 Epub: 2022 Dec 2 Authors Wang G , Wang X , Ma Y , Cai S , Yang L , Fan Y , Zeng X , Qiao S , |
|
|
Lactobacillus reuteri CCFM8631 Alleviates Hypercholesterolaemia Caused by the Paigen Atherogenic Diet by Regulating the Gut Microbiota. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 14 Issue 6 Pages: Pub: 2022 Mar 17 Epub: 2022 Mar 17 Authors Wang Q , He Y , Li X , Zhang T , Liang M , Wang G , Zhao J , Zhang H , Chen W , |
|
|
Lactobacillus reuteri FYNLJ109L1 Attenuating Metabolic Syndrome in Mice via Gut Microbiota Modulation and Alleviating Inflammation. ✅
Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 10 Issue 9 Pages: Pub: 2021 Sep 2 Epub: 2021 Sep 2 Authors Yang B , Zheng F , Stanton C , Ross RP , Zhao J , Zhang H , Chen W , |
|
|
Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis. ✅
Go to Publication ✅
Life sciences (Life Sci ) Vol: 314 Issue Pages: 121309 Pub: 2023 Feb 1 Epub: 2022 Dec 20 Authors Lin C , Zheng Y , Lu J , Zhang H , Wang G , Chen W , |
|
|
Limosilactobacillus reuteri Attenuates Atopic Dermatitis via Changes in Gut Bacteria and Indole Derivatives from Tryptophan Metabolism. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 14 Pages: Pub: 2022 Jul 13 Epub: 2022 Jul 13 Authors Fang Z , Pan T , Wang H , Zhu J , Zhang H , Zhao J , Chen W , Lu W , |
|
|
Protective effect of a newly probiotic Lactobacillus reuteri LY2-2 on DSS-induced colitis. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: 64 Issue 1 Pages: 5 Pub: 2024 Nov 15 Epub: 2024 Nov 15 Authors Yang Y , Qiao Y , Liu G , Yi G , Liu H , Zhang T , Tong M , |
|
|
Polygonatum kingianum Polysaccharides Enhance the Preventive Efficacy of Heat-Inactivated Limosilactobacillus reuteri WX-94 against High-Fat-High-Sucrose-Induced Liver Injury and Gut Dysbacteriosis. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 72 Issue 17 Pages: 9880-9892 Pub: 2024 May 1 Epub: 2024 Apr 22 Authors Liu T , Zhou L , Li X , Song W , Liu Y , Wu S , Wang P , Dai X , Shi L , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
